Minghui Pharmaceutical has reported promising initial outcomes from its Phase I trial of MHB039A to treat patients with solid ...
Ionis has announced the design for a Phase III trial of ION582, a treatment for Angelman syndrome (AS), following discussions with the FDA.
Alcon’s session at the 2024 Veeva MedTech Summit in Amsterdam. Image Credit: Ross Law / GlobalData. Alcon decided to take a ...
The former health minister predicted a bright future for UK trials and outlined steps to ensure clinical research thrives.